RE:RE:GGBTrendSwapper wrote: Aphria is going to do great this quarter. Hoping to see results of CC Pharma in this release, which generated 260 Million Euros in 2018! Going to be a very good Monday :)
This came out of the last MD&A. So I still dont understand where everyone (including APHA IR)is saying that there will be revenue from LHS divestment. So we already received $70.6M so where is the rest of the LHS revenue coming from?
Divesture of equity investment in passive US assets
The Company completed the sale of 80,148,077 of its shares in Liberty Health Sciences Inc. (“Liberty”) for $70,612 during the year-to-date period. The Company retained options to repurchase the 80,148,077 shares in Liberty, subject to the same Conditions as described above. The Company expects that, in the battle for market share once cannabis becomes legalized federally in the United States, the cost to acquire an interest in the United States cannabis market will significantly increase. These option agreements allow the Company an access point into the United States cannabis market at a price fixed before any increase arising from cannabis becoming a federally legal substance.